The Influence of MDR’s Article 117 in the Marketing of Combination Products
The European Union Medical Device Regulation’s (MDR) Article 117 brings improved patient safety measures with new implications for manufacturers, as...
Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Join Veristat and other Massachusetts life sciences companies at the MassBio Annual meeting, as they discuss the most critical challenges in bringing new products to market.
Opening Keynote by Kate Marshall, high school honors student, athlete and CF advocate
Closing Keynote by Dr. Tony Coles, Chairman & CEO, Yumanity Therapeutics
The MassBio Annual Meeting also includes the Innovative Leadership Award Luncheon, which honors an industry leader for his or her contribution to moving the life sciences industry forward.
Opening Keynote by Kate Marshall, high school honors student, athlete and CF advocate
Closing Keynote by Dr. Tony Coles, Chairman & CEO, Yumanity Therapeutics
The MassBio Annual Meeting focuses on the most critical challenges facing the Massachusetts life sciences industry. The meeting program is designed by a steering committee of industry leaders and the agenda encompasses keynote presentations, panel discussions, interactive working sessions and extensive networking opportunities.
The MassBio Annual Meeting also includes the Innovative Leadership Award Luncheon, which honors an industry leader for his or her contribution to moving the life sciences industry forward.
Opening Keynote by Kate Marshall, high school honors student, athlete and CF advocate
Closing Keynote by Dr. Tony Coles, Chairman & CEO, Yumanity Therapeutics
Featuring remarks from special guests:
Take advantage of the time at the event and schedule a time to meet with Veristat. We are a full-service CRO that can help guide you through the entire clinical development and regulatory process. Whether you need help writing your protocol, preparing for your regulatory submissions or need a partner to help bring your product from IND to NDA, look to Veristat for a truly collaborative partnership.
The European Union Medical Device Regulation’s (MDR) Article 117 brings improved patient safety measures with new implications for manufacturers, as...
GENESIS BIOMED recently interviewed Xavier Luria, former Head of Safety and Efficacy of Medicines at the European Medicines Agency (EMA), and now...
In the intricate dance of preparing marketing applications, the timeline serves as a choreographer, directing countless moving parts into a cohesive...